Actively Recruiting
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Led by Stanford University · Updated on 2025-06-15
41
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
CONDITIONS
Official Title
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed cervical cancer and planned brachytherapy as part of treatment
- ECOG performance status of 0 to 2
- Age 18 years or older
- Ability and willingness to provide written informed consent
You will not qualify if you...
- Contraindication to radiotherapy as assessed by treating radiation oncologist
- Contraindication to MRI
- Prior pelvic radiation therapy within the past 3 months
- Age under 18 years
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford University
Palo Alto, California, United States, 94304
Actively Recruiting
Research Team
A
Alyssa Alyssa
CONTACT
J
Jillian Skerchak
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here